
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Creative partnerships need realistic expectations and clear communication for successful product launch...and beyond.
over 25 years ago
The Power of Public Relationsover 25 years ago
Market Research 101over 25 years ago
World-Class Marketing Plansover 25 years ago
How to Win Friends and Influence R&Dover 25 years ago
A Strategic Overviewover 25 years ago
The Regulatory Environment





